Created at:1/13/2025
Question on this topic? Get an instant answer from August.
Ibritumomab mushonga wakanangana nekenza unosanganisa kurapa kwakanangana nemishonga yeradiyoactive kurwisa marudzi akati wandei ekenza yeropa. Mushonga uyu unoshanda semutsvaki wakanangana, uchitsvaga uye kunamatira kumasero ekenza akati wandei mumuviri wako usati wapa radiation yakananga kuvauraya. Inonyanya kushandiswa kurapa non-Hodgkin's lymphoma, rudzi rwekenza yeropa rinokanganisa hurongwa hwako hwelymphatic.
Ibritumomab mushonga we radioimmunotherapy unosanganisa antibody nechinhu chine radioactive. Funga nezvazvo sekurapa kwemativi maviri uko antibody inoshanda seGPS system, ichiwana masero ekenza, nepo chikamu chine radioactive chichipa radiation yakanangana kuvauraya. Zita rizere raungawana nderekuti ibritumomab tiuxetan, uye rinopihwa kuburikidza neIV line muropa rako.
Mushonga uyu ndewechikamu chinonzi monoclonal antibodies, izvo zvakagadzirirwa mapuroteni anogona kuziva uye kubatanidza kune zvinangwa zvakasiyana pamasero ekenza. Chinoita kuti ibritumomab ive yakasiyana ndeyekuti 'radiolabeled,' zvinoreva kuti inotakura radioactive material inogona kuuraya masero ekenza kubva mukati kana ichinge yabatana nawo.
Ibritumomab inobvumidzwa zvakananga kurapa marudzi akati wandei e non-Hodgkin's lymphoma, kunyanya follicular lymphoma uye mamwe maB-cell lymphomas. Chiremba wako angakurudzira kurapwa uku kana uine lymphoma yakadzoka mushure mekurapwa kumwe kana isina kupindura zvakanaka kune chemotherapy yakajairika.
Mushonga uyu unowanzo fungwa kana masero ako ekenza aine puroteni yakati wandei inonzi CD20 pamusoro pawo. Chikwata chako chehutano chichaedza masero ako ekenza kuti ave nechokwadi chekuti vane chinangwa ichi vasati vakurudzira ibritumomab. Inowanzo shandiswa sechikamu chechirongwa chekurapa chingasanganisira mamwe mishonga yekubatsira kugadzirira muviri wako uye kuvandudza kushanda kwekurapa.
Ibritumomab inoshanda nekutumira mheni yakanangana zvakananga kumasero ekenza ichideredza kukuvadza kumasero ane hutano. Chikamu che antibody chinotsvaga mapuroteni e CD20 anowanikwa pamusoro pemamwe masero e lymphoma. Kana yangowana uye yakanamatira kumasero aya, chikamu chine radioactive chinopa mheni yakatarwa iyo inoparadza masero ekenza kubva mukati.
Izvi zvinoonekwa sekurapa kenza kwakasimba zvishoma zvakanyanya uye kwakanangana kupfuura chemotherapy yechinyakare. Mheni yainopa ine huwandu hupfupi, zvinoreva kuti inonyanya kukanganisa masero ekenza ayo akabatana nawo panzvimbo yekupararira mumuviri wako wese. Iyi nzira yakatarwa inogona kubatsira kuderedza mamwe emigumisiro yaungave nayo nekushandisa mheni yakakura.
Ibritumomab inopiwa chete muchipatara kana nzvimbo yakakosha yekurapa kenza nevashandi vehutano vakadzidziswa. Uchaigamuchira kuburikidza ne IV line, zvinoreva kuti inoenda zvakananga muropa rako kuburikidza netsono muruoko rwako kana kuburikidza ne central line kana uine imwe.
Kurapa kunowanzo sanganisira infusions mbiri dzakasiyana dzakapiwa vhiki imwe chete. Pamberi pe infusion imwe neimwe, iwe unowanzo gamuchira mamwe mishonga yekubatsira kugadzirira muviri wako uye kuderedza njodzi yekugadzirisa allergic. Haufaniri kudya kana kudzivisa kudya usati watora mushonga, asi timu yako yehutano ichakupa mirairo yakatarwa zvichienderana nemamiriro ako ega.
Panguva ye infusion, iwe uchaongororwa zvakanyanya kune chero maitiro. Maitiro chaiwo e infusion anogona kutora maawa akati wandei, saka ungangoda kuunza chimwe chinhu chekuchengeta iwe uchinyaradzwa, senge bhuku kana mimhanzi. Mushure mekurapa, uchada kutevera matanho akakosha nekuti uchave uine radioactive material mumuviri wako kwemazuva mashoma.
Ibritumomab inowanzo kupihwa semushonga mumwe chete pane mushonga unopfuurira. Vanhu vazhinji vanogamuchira infusions mbiri dzinenge dziri mazuva manomwe kusvika mapfumbamwe akasiyana, uye izvozvo zvinopedzisa kutenderera kwekurapa. Kusiyana nemishonga yezuva nezuva, iyi inowanzo kuva kurapwa kamwe chete.
Chiremba wako achatarisa mhinduro yako kumushonga mumavhiki nemwedzi inotevera kuburikidza nemiedzo yeropa uye zvidzidzo zvekuona. Zvichienderana nekuti kenza yako inopindura sei uye hutano hwako hwese, timu yako yehutano inogona kukurudzira mamwe marapirwo, asi ibritumomab pachayo inowanzo kudzokororwa nekukasira nekuda kwemigumisiro yayo pamwongo wako wemapfupa.
Semamwe marapirwo ekenza, ibritumomab inogona kukonzera migumisiro, kunyangwe kwete munhu wese anoiziva nenzira imwechete. Zvakaipa zvakajairika zvine chekuita nemigumisiro yayo pamasero eropa ako uye immune system.
Heano zvakaipa zvaungangove uchiwana, uchifunga kuti timu yako yehutano ichakutarisa zvakanyanya uye ichabatsira kubata chero zviratidzo zvinomuka:
Vamwe vanhu vanogona kuwana zvakanyanya asi zvishoma zvakajairika zvakaipa. Izvi zvisingawanzoitiki zvinosanganisira kudonha kwakanyanya kwemasero eropa ayo anogona kuva anotyisa, kutapukirwa kwakakomba, kana kenzi yechipiri inogona kukura mwedzi kana makore gare gare. Timu yako yehutano ichakurukura njodzi idzi newe uye ichakutarisa zvakanyatso panguva uye mushure mekurapa.
Ibritumomab haikodzerani nemunhu wese, uye chiremba wako achanyatsoongorora kana yakakunakira. Hauzofaniri kugamuchira kurapwa uku kana wakazvitakura kana kuyamwisa, nekuti mheni inogona kukuvadza mwana ari kukura.
Chiremba wako achavawo akangwarira nezvekukurudzira ibritumomab kana uine mamwe mamiriro ehutano. Izvi zvinoda kufunga kwakakosha uye zvinogona kuita kuti kurapwa uku kusakunakire:
Vashandi vehutano vako vachaita bvunzo dzakazara vasati varapwa kuti vaone kuti muviri wako unogona kubata kurapwa uku zvakachengeteka. Vachafungawo nezvehutano hwako hwese, kurapwa kwakapfuura, uye mishonga iripo kuti vaone kana ibritumomab iri sarudzo yakanakisa yemamiriro ako chaiwo.
Ibritumomab inotengeswa pasi pezita rebrand Zevalin. Paunoona zita iri pane chirongwa chako chekurapa kana mapepa e inishuwarenzi, iri kureva mushonga mumwe chete. Vamwe vanopa hutano vanogona kushandisa zita rimwe kana vachikurukura nezvekurapa kwako, saka usavhiringike kana ukanzwa mazwi ese ari maviri.
Zevalin inogadzirwa nemakambani akakosha emishonga uye inowanikwa chete kuburikidza nenzvimbo dzakakosha dzekurapa kenza. Vashandi vehutano vako vachabatana nevashandi vakakodzera kuti vaone kuti unogamuchira mushonga paunouda.
Kana ibritumomab isingakunakire, dzimwe nzira dzekurapa dzinogona kuwanikwa yerudzi rwako rwe lymphoma. Chiremba wako anogona kukurudzira mamwe ma monoclonal antibodies se rituximab, iyo inotarisa iyo imwe chete CD20 protein asi haina zvinhu zvinopenya.
Dzimwe nzira dzekurapa dzinogona kusanganisira mhando dzakasiyana dzekurapa kwakatarwa, kusanganiswa kwemishonga yechinyakare yekenza, kana kurapwa kutsva senge CAR-T cell therapy, zvichienderana nemamiriro ako chaiwo. Chiremba wako weoncologist achashanda newe kuti awane kurapwa kwakakodzera zvichienderana nerudzi rwekenza yako, hutano hwako hwese, uye nhoroondo yekurapa.
Zvese ibritumomab uye rituximab zvinotarisa iyo imwechete CD20 protein pamaseru e lymphoma, asi anoshanda zvakasiyana. Rituximab ndeye "naked" antibody isingatakure radioactive material, nepo ibritumomab ichibatanidza antibody neradiation yakatarwa.
Zvidzidzo zvakaratidza kuti ibritumomab inogona kushanda zvakanyanya kupfuura rituximab yega mune dzimwe nguva, kunyanya ye follicular lymphoma yakadzoka mushure mekurapwa kumwe. Zvisinei, ibritumomab inotakurawo njodzi dzakawedzerwa nekuda kwechinhu chine radioactive, kusanganisira mhedzisiro yakakomba pamaseru eropa uye matambudziko angave ari kwenguva refu.
Sarudzo pakati pemishonga iyi inoenderana nezvinhu zvakawanda zvinosanganisira rudzi rwako rwe lymphoma, kurapwa kwakapfuura, hutano hwese, uye zvaunofarira. Chikwata chako chehutano chichakubatsira kuyera mabhenefiti anogona kuitika nenjodzi yesarudzo imwe neimwe kuti uite sarudzo yakanakisa yemamiriro ako.
Ibritumomab inogona kushandiswa muvanhu vane chirwere chemoyo, asi inoda kuongororwa nekuchenjerera uye kuongororwa. Chiremba wako wecardiologist uye oncologist vachashanda pamwechete kuti vaongorore kana mamiriro ako emoyo akagadzikana zvakakwana kuti abate kurapwa uye mhedzisiro yayo inogona kuitika.
Kunetsekana kukuru ndekwekuti ibritumomab inogona kukonzera kuverenga kwakaderera kwemaseru eropa, izvo zvinogona kuisa kushushikana kwakawanda pamoyo wako. Chikwata chako chehutano chichakutarisa zvakanyanya panguva yekurapa uye chinogona kugadzirisa chirongwa chako chekutarisira zvichienderana nekuti moyo wako unopindura sei.
Sezvo ibritumomab ichingopiwa nevashandi vehutano vakadzidziswa muzvipatara, kuwandisa kwemushonga netsaona hakusi kwakajairika. Mushonga unoverengwa zvakanyatsonaka zvichienderana nehuremu hwemuviri wako uye unopiwa pasi pekutariswa kwakanyanya kwechiremba.
Kana uine hanya nedosi yako kana uine zviratidzo zvisingajairiki mushure mekurapwa, taura nechikwata chako chehutano nekukasira. Vanogona kuongorora mamiriro ako uye kupa hanya yakakodzera kana zvichidikanwa. Nzvimbo yekurapa yaunogamuchira kurapwa ichava nemaitiro ekugadzirisa chero matambudziko angamuka.
Kana ukakanganwa infusion yako yeibritumomab yakarongwa, taura nechikwata chako chehutano nekukasira kuti urongezve. Nekuti kurapwa uku kunosanganisira radioactive material uye kunotevera chirongwa chakati rebei, zvakakosha kubatana nechikwata chako chekurapa pane kuyedza kugadzirisa chirongwa iwe pachako.
Chikwata chako chehutano chichasarudza nzira yakanakisa yekuenderera mberi zvichienderana nekuti yakawanda sei nguva yapfuura uye chirongwa chako chekurapa chose. Vanogona kuda kutangazve mamwe mishonga yekugadzirira kana kugadzirisa nguva yechikamu chako chekurapa.
Ibritumomab inowanzo piwa sechinhu chakazara chekurapa pane mushonga unopfuurira. Vanhu vazhinji vanogamuchira infusions mbiri vachipatsanurwa neviki rimwe, uye izvo zvinopedzisa kurapwa. Hauwanzoti "mira" kutora ibritumomab nenzira imwecheteyo yaungamira mushonga wezuva nezuva.
Mushure mekunge chikamu chako chekurapa chapera, chikwata chako chehutano chichatarisa mhinduro yako kuburikidza nekutarisa nguva dzose, bvunzo dzeropa, uye zvidzidzo zvekufungidzira. Vachakuzivisa kana chero mamwe marapirwo achidikanwa zvichienderana nekuti kenza yako inopindura sei.
Chinhu chine radioactive muna ibritumomab chine hafu-hupenyu hupfupi, zvinoreva kuti chinorasikirwa ne radioactivity nekukurumidza. Ruzhinji rwe radioactivity ruchabva mumuviri wako mukati memavhiki maviri mushure mekurapwa, nemazinga akakwirira aripo mumazuva mashoma ekutanga.
Munguva iyi, uchada kutevera matanho ekuchengetedza akakosha kudzivirira vamwe kubva pakuratidzwa kwemwaranzi. Chikwata chako chekuchengetedza hutano chichakupa mirairo yakadzama yekugara kure nevamwe, kunyanya vakadzi vane pamuviri nevana vadiki, uye kurasa zvakanaka zvemumuviri. Matanho aya ekuchengetedza ndeechinguvana uye achabviswa kana radioactivity yaderera kusvika kumazinga akachengeteka.